Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making

BACKGROUND: Newborn screening aims to identify individual patients who could benefit from early management, treatment, and/or surveillance practices. As sequencing technologies have progressed and we move into the era of precision medicine, genomic sequencing has been introduced to this area with th...

Descripción completa

Detalles Bibliográficos
Autores principales: DeCristo, Daniela M., Milko, Laura V., O’Daniel, Julianne M., Foreman, Ann Katherine M., Mollison, Lonna F., Powell, Bradford C., Powell, Cynthia M., Berg, Jonathan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008582/
https://www.ncbi.nlm.nih.gov/pubmed/33781310
http://dx.doi.org/10.1186/s13073-021-00867-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008582/
https://www.ncbi.nlm.nih.gov/pubmed/33781310
http://dx.doi.org/10.1186/s13073-021-00867-1

Ejemplares similares